BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37060681)

  • 1. Effects of delayed callback from screening mammography due to the COVID-19 pandemic.
    Chamadoira J; Au F; Ghai S; Kulkarni S; Grant A; Fleming R; Alvarenga P; Freitas V
    Clin Imaging; 2023 Jul; 99():41-46. PubMed ID: 37060681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic interval for non-screening patients undergoing mammography during the COVID-19 pandemic.
    Crivellaro P; Tafur M; George R; Muradali D
    Eur Radiol; 2022 Jan; 32(1):613-620. PubMed ID: 34143286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in Same-Day Diagnostic Imaging in Breast Cancer Screening: Impact of an Immediate-Read Screening Mammography Program Implemented During the COVID-19 Pandemic.
    Dontchos BN; Achibiri J; Mercaldo SF; Wang GX; Lamb LR; Miles RC; Narayan AK; Lehman CD
    AJR Am J Roentgenol; 2022 Feb; 218(2):270-278. PubMed ID: 34494449
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast and Lung Cancer Screening Among Medicare Enrollees During the COVID-19 Pandemic.
    Doan C; Li S; Goodwin JS
    JAMA Netw Open; 2023 Feb; 6(2):e2255589. PubMed ID: 36735262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
    Sung JS; Stamler S; Brooks J; Kaplan J; Huang T; Dershaw DD; Lee CH; Morris EA; Comstock CE
    Radiology; 2016 Sep; 280(3):716-22. PubMed ID: 27097237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Outcomes for One-View Asymmetries Recalled From Digital Breast Tomosynthesis Versus Full-Field Digital Mammography Screening Examinations.
    Gong AJ; Nguyen DL; Lee EE; Mullen LA; Myers KS; Oluyemi E; Ambinder EB
    AJR Am J Roentgenol; 2022 Nov; 219(5):724-733. PubMed ID: 35703412
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic Evaluation of Recalled Noncalcified Lesions Using Ultrasound Alone Versus Ultrasound Plus Additional Mammographic Views: A Prospective Study.
    Porembka JH; Seiler SJ; Sharifi A; Mootz AR; Knippa E; Evans WP; Chen H; Xi Y; Dogan BE
    AJR Am J Roentgenol; 2022 Jun; 218(6):977-987. PubMed ID: 34910533
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer.
    Choi SH; Choi JS; Han BK; Ko EY; Ko ES; Park KW
    Radiology; 2019 Jul; 292(1):37-48. PubMed ID: 31038406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast MRI as an adjunct to mammography for breast cancer screening in high-risk patients: retrospective review.
    Raikhlin A; Curpen B; Warner E; Betel C; Wright B; Jong R
    AJR Am J Roentgenol; 2015 Apr; 204(4):889-97. PubMed ID: 25794083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-Based Breast Cancer Screening Using Digital Breast Tomosynthesis Versus Digital Mammography: Comparison of Screening Performance and Tumor Characteristics.
    Regen-Tuero HC; Ram S; Gass JS; Lourenco AP
    AJR Am J Roentgenol; 2022 Feb; 218(2):249-257. PubMed ID: 34523954
    [No Abstract]   [Full Text] [Related]  

  • 11. Dense Breast Ultrasound Screening After Digital Mammography Versus After Digital Breast Tomosynthesis.
    Dibble EH; Singer TM; Jimoh N; Baird GL; Lourenco AP
    AJR Am J Roentgenol; 2019 Dec; 213(6):1397-1402. PubMed ID: 31553658
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.
    Nelson HD; O'Meara ES; Kerlikowske K; Balch S; Miglioretti D
    Ann Intern Med; 2016 Feb; 164(4):226-35. PubMed ID: 26756902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Yield and Patterns of Follow-up for BI-RADS Category 3 after Screening Mammography Recall in the National Mammography Database.
    Berg WA; Berg JM; Sickles EA; Burnside ES; Zuley ML; Rosenberg RD; Lee CS
    Radiology; 2020 Jul; 296(1):32-41. PubMed ID: 32427557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening Mammography Recovery After COVID-19 Pandemic Facility Closures: Associations of Facility Access and Racial and Ethnic Screening Disparities.
    Lehman CD; Mercaldo SF; Wang GX; Dontchos BN; Specht MC; Lamb LR
    AJR Am J Roentgenol; 2022 Jun; 218(6):988-996. PubMed ID: 34817192
    [No Abstract]   [Full Text] [Related]  

  • 15. Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.
    Epstein MM; Sundaresan D; Fair M; Fouayzi H; Warner ET; Garber LD; Gurwitz JH; Field TS
    Cancer Causes Control; 2022 Oct; 33(10):1313-1323. PubMed ID: 35933572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.
    Duijm LE; Groenewoud JH; de Koning HJ; Coebergh JW; van Beek M; Hooijen MJ; van de Poll-Franse LV
    Eur J Cancer; 2009 Mar; 45(5):774-81. PubMed ID: 19046632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Mammography Screening Trends and Predictors of Return to Screening after the COVID-19 Pandemic: Results from a Statewide Registry.
    Sprague BL; Nowak SA; Ahern TP; Herschorn SD; Kaufman PA; Odde C; Perry H; Sowden MM; Vacek PM; Weaver DL
    Radiol Imaging Cancer; 2024 May; 6(3):e230161. PubMed ID: 38578209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: the SomoInsight Study.
    Brem RF; Tabár L; Duffy SW; Inciardi MF; Guingrich JA; Hashimoto BE; Lander MR; Lapidus RL; Peterson MK; Rapelyea JA; Roux S; Schilling KJ; Shah BA; Torrente J; Wynn RT; Miller DP
    Radiology; 2015 Mar; 274(3):663-73. PubMed ID: 25329763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic development of an abbreviated protocol for screening breast magnetic resonance imaging.
    Strahle DA; Pathak DR; Sierra A; Saha S; Strahle C; Devisetty K
    Breast Cancer Res Treat; 2017 Apr; 162(2):283-295. PubMed ID: 28138893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neglecting to screen women between the ages of 40 and 49 years with mammography: what is the impact on breast cancer diagnosis?
    Kremer ME; Downs-Holmes C; Novak RD; Lyons JA; Silverman P; Pham RM; Plecha DM
    AJR Am J Roentgenol; 2012 May; 198(5):1218-22. PubMed ID: 22528917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.